Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Lifecore Biomedical (LFCR) Interest & Investment Income: 2009-2025

Historic Interest & Investment Income for Lifecore Biomedical (LFCR) over the last 17 years, with May 2025 value amounting to -$21.8 million.

  • Lifecore Biomedical's Interest & Investment Income fell 7.14% to -$8.9 million in Q2 2025 from the same period last year, while for May 2025 it was -$22.1 million, marking a year-over-year decrease of 89.35%. This contributed to the annual value of -$21.8 million for FY2025, which is 20.70% down from last year.
  • Per Lifecore Biomedical's latest filing, its Interest & Investment Income stood at -$21.8 million for FY2025, which was down 20.70% from -$18.1 million recorded in FY2024.
  • Lifecore Biomedical's 5-year Interest & Investment Income high stood at $81,000 for FY2022, and its period low was -$21.8 million during FY2025.
  • Over the past 3 years, Lifecore Biomedical's median Interest & Investment Income value was -$18.1 million (recorded in 2024), while the average stood at -$13.3 million.
  • Per our database at Business Quant, Lifecore Biomedical's Interest & Investment Income surged by 68.75% in 2022 and then slumped by 26,702.94% in 2024.
  • Over the past 5 years, Lifecore Biomedical's Interest & Investment Income (Yearly) stood at $48,000 in 2021, then surged by 68.75% to $81,000 in 2022, then decreased by 16.05% to $68,000 in 2023, then tumbled by 26,702.94% to -$18.1 million in 2024, then dropped by 20.70% to -$21.8 million in 2025.